Bringing Therapies to Patients When Standard Channels Fail
When the medicine a patient needs is unavailable, unlicensed locally, or in shortage, treatment can stall.
We facilitate compliant access, delivering to hospitals, care centers, and pharmacies when no standard route exists. This includes coordinating the right pathway, assembling documentation, managing authority interactions, and delivering temperature-controlled products with full traceability.
Access to essential medicines often faces regulatory and supply barriers. Our treatment access solutions enable global access to locally unlicensed therapies, address temporary shortages, and support cross-border supply.
We help innovative treatments reach the point of care when standard channels fall short, because getting therapy to the patients who need them is what matters most.
We enable global, safe and compliant access to treatment.
Need a Product?
Tell us what you're looking for and we'll route your enquiry to the right team.
Whether it's a comparator, ancillary supply, unlicensed medicine, named patient request or a specific product requirement, we'll review your enquiry and respond with the most appropriate solution.
Our Treatment Access Solutions
Individual ImportPatient-Specific Access to Non-Marketed Innovations. Expands care options with compliant access to innovative therapies approved outside the local market for clinically justified cases.
Shortage ResolutionRestore continuity of care during supply disruptions. Proactive market scanning, authority collaboration, qualified alternatives, and controlled distribution to keep care sites supplied.
Why Komtur?
Patient-First, Care-Centric Handling
Single case owner, transparent status, and checklist documentation help keep cases moving and care continuous.
Speed with Certainty
Bonded-warehouse release, established customs and Importer of Record (IOR) workflows, and temperature-controlled last-mile delivery to hospital or pharmacy receipt.
Licensed Global Access Network
Quality-assured sourcing with falsified-medicines safeguards, serialization, and end-to-end batch traceability.
Authority-Aligned, Multi-Country Enablement
Correct use of named-patient and shortage pathways, plus practical broker and IOR guidance as well as documentation support.
Proactive Access Insights
Continuous shortage and regulatory-approval monitoring, demand validation, and early qualification of alternatives to protect continuity of care.
Most access cases fail in the gaps between regulation, documentation, and logistics. Closing those gaps is what keeps treatment moving.